TrustCore Financial Services’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-400
Closed -$3K 1117
2022
Q3
$3K Hold
400
﹤0.01% 935
2022
Q2
$3K Hold
400
﹤0.01% 912
2022
Q1
$5K Buy
+400
New +$8.42K ﹤0.01% 852
2021
Q4
Sell
-400
Closed -$19K 1015
2021
Q3
$19K Hold
400
﹤0.01% 655
2021
Q2
$18K Sell
400
-75
-16% -$3.32K ﹤0.01% 648
2021
Q1
$23K Hold
475
﹤0.01% 566
2020
Q4
$26K Hold
475
﹤0.01% 514
2020
Q3
$18K Hold
475
﹤0.01% 520
2020
Q2
$15K Buy
475
+75
+19% +$2.08K ﹤0.01% 567
2020
Q1
$11K Hold
400
﹤0.01% 573
2019
Q4
$12K Hold
400
﹤0.01% 607
2019
Q3
$8K Hold
400
﹤0.01% 679
2019
Q2
$9K Buy
+400
New +$8.78K ﹤0.01% 655

Other funds holding NEO

TrustCore Financial Services's NEO Position: Q4 2022 in Review

TrustCore Financial Services sold out of NeoGenomics (NEO) in Q4 2022, closing a stake of 400 shares — an estimated $3K sold.

TrustCore Financial Services first reported a position in NEO in Q2 2019 and held it in 13 quarters. The position peaked at $26K in Q4 2020. 244 funds tracked by Wall St. Rank hold NEO as of Q4 2022.

  • TrustCore Financial Services reported no remaining NeoGenomics position as of Q4 2022 after selling out during the quarter.
  • TrustCore Financial Services sold 400 NeoGenomics shares in Q4 2022, an estimated $3K.
  • TrustCore Financial Services first reported a position in NeoGenomics in Q2 2019 and held it in 13 quarters.
  • TrustCore Financial Services's NeoGenomics position peaked at $26K in Q4 2020.
  • 244 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.